Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients with Unresectable Pancreatic Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 94, Issue 3, 2016, Pages 571-579

  Wild, Aaron T ^a   Herman, Joseph M ^b   Dholakia, Avani S ^b   Moningi, Shalini ^b   Lu, Yao ^c   Rosati, Lauren M ^b   Hacker Prietz, Amy ^b   Assadi, Ryan K ^b   Saeed, Ali M ^b   Pawlik, Timothy M ^c   Jaffee, Elizabeth M ^c   Laheru, Daniel A ^c   Tran, Phuoc T ^b   Weiss, Matthew J ^c   Wolfgang, Christopher L ^c   Ford, Eric ^d   Grossman, Stuart A ^c   Ye, Xiaobu ^c   Ellsworth, Susannah G ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; LYMPHOCYTES; MULTIVARIANT ANALYSIS; RADIATION; RADIOTHERAPY;

CHEMORADIATION THERAPIES; CONFIDENCE INTERVAL; LOCALLY ADVANCED PANCREATIC CANCERS; METHODS AND MATERIALS; MULTIVARIATE ANALYSIS; PLANNING TARGET VOLUMES; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT TECHNIQUES;

PATIENT TREATMENT;

CAPECITABINE; CONTRAST MEDIUM; FLUOROURACIL; GEMCITABINE; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; CONVENTIONAL CHEMORADIATION THERAPY; DISEASE SEVERITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; LOCALLY ADVANCED PANCREATIC CANCER; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MULTICENTER STUDY; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL; PLANNING TARGET VOLUME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INDUCED LYMPHOPENIA; RADIATION INJURY; RADIOLOGICAL PARAMETERS; STEREOTACTIC BODY RADIATION THERAPY; ADENOCARCINOMA; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; LYMPHOPENIA; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; RADIATION DOSE FRACTIONATION; RADIOSURGERY;

ADENOCARCINOMA; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY; DEOXYCYTIDINE; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; LYMPHOCYTE COUNT; LYMPHOPENIA; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; RADIOSURGERY;

EID: 84963726148     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.11.026     Document Type: Article

References (33)

1. S.A. Grossman, X. Ye, G. Lesser, and et al. Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide Clin Cancer Res 17 2011 5473 5480
2. J.L. Campian, X. Ye, M. Brock, and et al. Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer Cancer Invest 31 2013 183 188
3. A. Balmanoukian, X. Ye, J. Herman, and et al. The association between treatment-related lymphopenia and survival in newly diagnosed patients with resected adenocarcinoma of the pancreas Cancer Invest 30 2012 571 576
4. A.T. Wild, X. Ye, S.G. Ellsworth, and et al. The association between chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma Am J Clin Oncol 38 2015 259 265
5. M.A. Hughes, M. Parisi, S. Grossman, and et al. Primary brain tumors treated with steroids and radiotherapy: Low CD4 counts and risk of infection Int J Radiat Oncol Biol Phys 62 2005 1423 1426
6. K.K. Meyer Radiation-induced lymphocyte-immune deficiency. A factor in the increased visceral metastases and decreased hormonal responsiveness of breast cancer Arch Surg 101 1970 114 121
7. M. Onsrud, I. Grahm, and G. Gaudernack Early stage carcinoma of the uterine cervix. Effects of intracavitary radium treatment on lymphoid cells in blood and pelvic lymph nodes Acta Radiol Oncol 25 1986 127 130
8. I.C. MacLennan, and H.E. Kay Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation Cancer 41 1978 108 111
9. E. Weeke The development of lymphopenia in uremic patients undergoing extracorporeal irradiation of the blood with portable beta units Radiat Res 56 1973 554 559
10. S. Yovino, L. Kleinberg, S.A. Grossman, and et al. The etiology of treatment-related lymphopenia in patients with malignant gliomas: Modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells Cancer Invest 31 2013 140 144
11. N. Nakamura, Y. Kusunoki, and M. Akiyama Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay Radiat Res 123 1990 224 227
12. L. Potters, B. Kavanagh, J.M. Galvin, and et al. American society for therapeutic radiology and oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 76 2010 326 332
13. J.M. Herman, D.T. Chang, K.A. Goodman, and et al. Phase II multi-institutional trial evaluating gemcitabine and stereotactic body radiation therapy for locally advanced unresectable pancreatic adenocarcinoma Cancer 121 2015 1128 1137
14. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: The next generation Cell 144 2011 646 674
15. R.D. Schreiber, L.J. Old, and M.J. Smyth Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion Science 331 2011 1565 1570
16. L. Zhang, J.R. Conejo-Garcia, D. Katsaros, and et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N Engl J Med 348 2003 203 213
17. S. Loi, N. Sirtaine, F. Piette, and et al. Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98 J Clin Oncol 31 2013 860 867
18. + tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma Pancreas 28 2004 26 31
19. Y. Ino, R. Yamazaki-Itoh, K. Shimada, and et al. Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer Br J Cancer 108 2013 914 923
20. J. Shohan Some theoretical considerations on the present status of roentgen therapy The Boston Medical and Surgical Journal 175 1916 321 327
21. M. Raben, N. Walach, U. Galili, and et al. The effect of radiation therapy on lymphocyte subpopulations in cancer patients Cancer 37 1976 1417 1421
22. K. Idestrom, B. Petrini, H. Blomgren, and et al. Changes of the peripheral lymphocyte population following radiation therapy to extended and limited fields Int J Radiat Oncol Biol Phys 5 1979 1761 1766
23. R. Lee, S. Yamada, N. Yamamoto, and et al. Chromosomal aberrations in lymphocytes of lung cancer patients treated with carbon ions J Radiat Res 45 2004 195 199
24. C. Tang, Z. Liao, D. Gomez, and et al. Lymphopenia association with gross tumor volume and lung V5 and its effect on non-small cell lung cancer patient outcomes Int J Radiat Oncol Biol Phys 89 2014 1084 1091
25. C.L. Mackall, T.J. Fry, and R.E. Gress Harnessing the biology of IL-7 for therapeutic application Nat Rev Immunol 11 2011 330 342
26. S. Ellsworth, A. Balmanoukian, F. Kos, and et al. Sustained CD4 T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomide Oncoimmunology 3 2014 27357
27. P. Kuo, S.V. Bratman, D.B. Shultz, and et al. Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response Clin Cancer Res 20 2014 5558 5569
28. W.F. Regine, K.A. Winter, R.A. Abrams, and et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial JAMA 299 2008 1019 1026
29. D.T. Chang, D. Schellenberg, J. Shen, and et al. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas Cancer 115 2009 665 672
30. J.M. Herman, A.T. Wild, H. Wang, and et al. Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: Final results J Clin Oncol 31 2013 886 894
31. P.J. Loehrer, Y. Feng, H. Cardenes, and et al. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial J Clin Oncol 29 2011 4105 4112
32. M.J. Mackenzie, D. Saltman, H. Hirte, and et al. A phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortium Invest New Drugs 25 2007 553 558
33. H.L. Kindler, T. Ioka, D.J. Richel, and et al. Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: A double-blind randomised phase 3 study Lancet Oncol 12 2011 256 262